Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling
SCOTUS revisits enablement, but Amgen v. Sanofi probably won’t transform patent law on its own.

SCOTUS revisits enablement, but Amgen v. Sanofi probably won’t transform patent law on its own.

Most doctors want a federal medical license. But would the Constitution allow Congress to control accreditation?

The federal government is failing to use the powers it has beyond vaccine mandates to create much needed on-ramps for mitigation measures.

We have entered a new stage of erasure of children, of the disabled, and of the vulnerable.

The federal government has all the power it needs to stop the actions of individual states that put the entire nation at risk.

Among several important themes, the need to regulate the access to clinical data of patients, also called “interoperability,” arises as a major one.
